Accuracy of 18F fluorodeoxyglucose positron emission tomography/computed tomography in staging of pediatric sarcomas

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 9, 2007, Pages 608-612

  Tateishi, Ukihide ^a,c   Hosono, Ako ^a   Makimoto, Atsushi ^a   Sakurada, Aine ^a   Terauchi, Takashi ^b   Arai, Yasuaki ^a   Imai, Yutaka ^c   Kim, Euishin Edmund ^d  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c TOKAI UNIVERSITY   (Japan)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Pediatric sarcoma; PET CT; Stage

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOMA; TISSUE INJURY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SARCOMA;

EID: 34548405561     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318142b5ab     Document Type: Article

References (20)

1. Franzius C, Bielack S, Flege S, et al. Prognostic significance of (18)F-FDG and (99 m)Tc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med. 2002;43:1012-1017.
2. Hawkins DS, Rajendran JG, Conrad EU III, et al. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer. 2002;94:3277-3284.
3. Breneman JC, Lyden E, Pappo AS, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol. 2003;21:78-84.
4. Nieweg OE, Pruim J, van Ginkel RJ, et al. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med. 1996;37:257-261.
5. Franzius C, Sciuk J, Daldrup-Link HE, et al. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med. 2000;27:1305-1311.
6. Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med. 2000;41:1695-1701.
7. Franzius C, Daldrup-Link HE, Sciuk J, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol. 2001;12:479-486.
8. Bredella MA, Caputo GR, Steinbach LS. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas. Am J Roentgenol. 2002;179:1145-1150.
9. Somer EJ, Marsden PK, Benatar NA, et al. PET-MR image fusion in soft tissue sarcoma: accuracy, reliability and practicality of interactive point-based and automated mutual information techniques. Eur J Nucl Med Mol Imaging. 2003;30:54-62.
10. Vernon CB, Eary JF, Rubin BP, et al. FDG PET imaging guided re-evaluation of histopathologic response in a patient with high-grade sarcoma. Skeletal Radiol. 2003;32:139-142.
11. Feldman F, van Heertum R, Manos C. 18FDG PET scanning of benign and malignant musculoskeletal lesions. Skeletal Radiol. 2003;32:201-208.
12. McCarville MB, Christie R, Daw NC, et al. PET/CT in the evaluation of childhood sarcomas. Am J Roentgenol. 2005;184:1293-1304.
13. Shulkin BL, Mitchell DS, Ungar DR, et al. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies. Radiology. 1995;194:495-500.
14. Daldrup-Link HE, Franzius C, Link TM, et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. Am J Roentgenol. 2001;177:229-236.
15. Ben Arush MW, Israel O, Kedar Z, et al. Detection of isolated distant metastasis in soft tissue sarcoma by fluorodeoxyglucose positron emission tomography: a case report. J Pediatr Hematol Oncol. 2001;18:295-298.
16. Wegner EA, Barrington SF, Kingston JE, et al. The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging. 2005;32:23-30.
17. Smith K, Hamza S, Skelton H. Epithelioid sarcoma follow-up and early detection with CA-125 and PET-CT scan. Am J Dermatopathol. 2006;28:229.
18. Vasanawala MS, Wang Y, Quon A, et al. F-18 Fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp. Clin Nucl Med. 2006;31:534-537.
19. Oe A, Habu D, Kawabe J, et al. A case of diffuse hepatic angiosarcoma diagnosed by FDG-PET. Ann Nucl Med. 2005;19:519-521.
20. Brenner W, Bohuslavizki KH, Eary JF. PET imaging of osteosarcoma. J Nucl Med. 2003;44:930-942.